Provided by Tiger Fintech (Singapore) Pte. Ltd.

SPYRE THERAPEUTICS INC

14.75
-0.1800-1.21%
Post-market: 14.750.00000.00%16:05 EDT
Volume:1.03M
Turnover:15.01M
Market Cap:890.22M
PE:-4.91
High:14.96
Open:14.96
Low:14.13
Close:14.93
Loading ...
Nov 07, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Nov 07, 2024

Major Issues Report

Form 8-K - Current report
Nov 07, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 25, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Oct 23, 2024

Beneficial Ownership Change

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Oct 15, 2024

Major Issues Report

Form 8-K - Current report
Oct 01, 2024

Correspondence

Form CORRESP - Correspondence
Sep 14, 2024

Correspondence

Form CORRESP - Correspondence
Aug 08, 2024

Major Issues Report

Form 8-K/A - Current report: [Amend]
Aug 07, 2024

Major Issues Report

Form 8-K - Current report
Aug 07, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 30, 2024

Major Issues Report

Form 8-K - Current report
May 15, 2024

Major Issues Report

Form 8-K - Current report
May 09, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 09, 2024

Major Issues Report

Form 8-K - Current report
Apr 26, 2024

Correspondence

Form CORRESP - Correspondence
Apr 25, 2024

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Apr 25, 2024

Major Issues Report

Form 8-K - Current report
Apr 23, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Apr 19, 2024

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933